Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen MacKay

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Cells|March 1, 2019
Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open QuestionsMarina Bagnoli, Ting Yan Shi, Charlie Gourley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical CancerKathy Han, Jinfeng Zou, Zhen Zhao, et al.
Nature Communications|March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinomaAinhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2020
Human settlement of East Polynesia earlier, incremental, and coincident with prolonged South Pacific droughtDavid A Sear, Melinda S Allen, Jonathan D Hassall, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2016
Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric CancerRebecca B Goody, Helen MacKay, Bethany Pitcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2023
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005Jung-Min Lee, Mark F Brady, Austin Miller, et al.
Nature Communications|March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patientsNanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Cells|March 1, 2019
Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open QuestionsMarina Bagnoli, Ting Yan Shi, Charlie Gourley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical CancerKathy Han, Jinfeng Zou, Zhen Zhao, et al.
Nature Communications|March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinomaAinhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2020
Human settlement of East Polynesia earlier, incremental, and coincident with prolonged South Pacific droughtDavid A Sear, Melinda S Allen, Jonathan D Hassall, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2016
Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric CancerRebecca B Goody, Helen MacKay, Bethany Pitcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2023
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005Jung-Min Lee, Mark F Brady, Austin Miller, et al.
Nature Communications|March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patientsNanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
Pageof 7